Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Xiao-Rong Pan"'
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundRecently, some genomic mutations in exosomal DNA have been found to be related to disease progress and clinical outcomes of patients in several cancers. Unfortunately, the methods for exosome isolation and exosomal DNA analysis are still la
Externí odkaz:
https://doaj.org/article/cbba59582e43441484bff872f8ab72f8
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Clinical management of metastatic gastric cancer (mGC) remains a major challenge due to a lack of specific biomarkers and effective therapeutic targets. Recently, accumulating evidence has suggested that exosomes play an essential role in
Externí odkaz:
https://doaj.org/article/4754f7e240be442da70a28cb95a3b615
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: The research on circulating tumor DNA (ctDNA) in pancreatic cancer (PC) has emerged recently. Although the detection rate of the KRAS mutation in ctDNA was relatively consistent with that in tumor tissue, whether the KRAS mutant allele fr
Externí odkaz:
https://doaj.org/article/0f648d8d301b40cf90df98a6bc4ed95d
Autor:
Jing-Ni Zhu, Lu Jiang, Jing-Hua Jiang, Xue Yang, Xiao-Yong Li, Jian-Xin Zeng, Rong-Yu Shi, Yang Shi, Xiao-Rong Pan, Zhi-Peng Han, Li-Xin Wei
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract Hepatocyte nuclear factor-1beta plays an important role in the development and progression of liver cancer. In recent years, the expression of HNF-1β has been reported to be associated with risk for a variety of cancers. The purpose of this
Externí odkaz:
https://doaj.org/article/627233bcdea94e5ea8eba5a1d42f27ee
Autor:
Xuan Zhang, Di Xia, Rui-Xian Wang, Ying-Ting Zhang, Si-Ying Zhang, Cheng Yang, Xiao-Rong Pan, Jian-Hua Tong
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 531
Poor prognosis of digestive system cancers is mainly owing to lack of accurate and timely diagnosis. The exploration of novel tumor biomarkers from extracellular vesicle (EV) might be helpful to clinical diagnosis for digestive system cancers.Several
Autor:
Lu Gao, Ying-ying Jing, Xiao-Rong Pan, Zhipeng Han, Qiu-dong Zhao, Rong Li, Lixin Wei, Xiao-juan Hou, Yan Meng, Yang Yang, Xue Yang, Wenting Liu
Publikováno v:
Cell Death Differ
Hepatocellular carcinoma (HCC) generally occurs in the presence of chronic liver injury, often as a sequela of liver fibrosis. Hepatic progenitor cells (HPCs) are known to be capable of forming both hepatocytes and cholangiocytes in chronic liver inj
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
Background Recently, some genomic mutations in exosomal DNA have been found to be related to disease progress and clinical outcomes of patients in several cancers. Unfortunately, the methods for exosome isolation and exosomal DNA analysis are still l
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
Background: Clinical management of metastatic gastric cancer (mGC) remains a major challenge due to a lack of specific biomarkers and effective therapeutic targets. Recently, accumulating evidence has suggested that exosomes play an essential role in
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology
Frontiers in Oncology
Background: The research on circulating tumor DNA (ctDNA) in pancreatic cancer (PC) has emerged recently. Although the detection rate of the KRAS mutation in ctDNA was relatively consistent with that in tumor tissue, whether the KRAS mutant allele fr
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 27(3)
To establish a method for detecting the exosomal PML-RARA fusion gene expression by droplet digital PCR (ddPCR).By using Taqman probe-based ddPCR technique, the method that able to detect both long and short isoforms of PML-RARA fusion gene transcrip